Ospedale Misericordia - Grosseto

Wearing Protection or Wearing Assumptions? A Critical Reappraisal of the Wearable Cardioverter-Defibrillator

The wearable cardioverter-defibrillator (WCD) has become an accepted temporary strategy for patients considered at transient risk of sudden cardiac death and its use has rapidly expanded across a broad range of clinical settings. However, more than twenty years after its introduc...

LDL Cholesterol Lowering With Evolocumab Before Percutaneous Coronary Intervention for Acute Myocardial Infarction

Importance: Proprotein convertase subtilisin-kexin type 9 (PCSK9) inhibition is recommended as second- or third-line lipid-lowering therapy after myocardial infarction (MI), resulting in prolonged periods of inadequate low-density lipoprotein cholesterol (LDL-C) control. Whether...